Redox, healthcare’s leading integration platform, announced it has been granted U.S. Patent No. 9,996,664 by the United States Patent and Trademark Office for its systems and methods for translating messages between healthcare delivery organizations and technology vendors. Leveraging a series of reusable configuration records, Redox standardizes how medical record content is represented and enables true interoperability between entities that exchange data. The Redox Platform streamlines data exchange between members of the Redox Network.

“Electronic medical records are notorious for inconsistencies in data format and representation. This variation has made it difficult for healthcare delivery organizations to exchange information with affiliates and technology vendors,” said James Lloyd, co-founder and chief technology officer at Redox. “The Redox Platform establishes reusable infrastructure to scale healthcare data exchange across many partners. This approach fundamentally changes the way healthcare organizations exchange data. We believe the methodology covered by this patent is the key to solving healthcare’s biggest interoperability challenges.” Read the full story here.